1-5 of 5
Shanti Natarajan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Azacitidine for Patients with Vexas Syndrome: Data from the French Vexas Registry

Thibault Comont, Olivier Kosmider, Mael Heiblig, Benjamin Terrier, Didier Bouscary, Guillaume Le Guenno, Roderau Outh, Maxime Samson, Achille Aouba, Estibaliz Lazarro, Odile Rauzy, Lucie Rigolot, Pierre Peterlin, Alexandre Maria, Edouard Flammarion, Alice Garnier, Benoit De Renzis, Shanti Natarajan, Benjamin Carpentier, Marielle Roux-Sauvat, Jose Torregrosa, Fabienne Closs-Prophette, Julien Rossignol, Nicolas Schleinitz, Celine Dieval, Jonahan Broner, Marie-Pierre Gourin, Gaetan Sauvetre, Benoit Faucher, Julien Vinit, Sylvie Grosleron, Alexis Mathian, Louis Terriou, Cyrille Coustal, Philippe Guilpain, Paola Marianetti-Guingel, Holy Bezanahary, Norbert Vey, Bilal Mohty, Thomas Moulinet, Vincent Grobost, Sophie Dimicoli, Benoit Suzon, Antoinette Perlat, Pierre Hirsh, Lise Larcher, Lin Pierre Zhao, Sophie Georgin-Lavialle, Arsene Mekinian, Pierre Fenaux, Vincent Jachiet, French VEXAS study group, Minhemon French Network of immune disorders associated with hemopathies, GFM Groupe Francophone des Myélodysplasies
Journal: Blood
Blood (2023) 142 (Supplement 1): 4604.
https://doi.org/10.1182/blood-2023-178125
Published: 2023
Journal Articles

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

Valeria Santini, Jennifer Schemenau, Alessandro Levis, Enrico Balleari, Rosa Sapena, Lionel Adès, Agnès Guerci, Odile Beyne-Rauzy, Marie-Pierre Gourin, Stephane Cheze, Aspasia Stamatoullas, Alessandro Sanna, Daniela Gioia, Gianni Cametti, Dario Ferrero, Emmanuel Raffoux, Christian Rose, Antonella Poloni, Thomas Prebet, Laurence Legros, Shanti Natarajan-Amé, Pierre Fenaux, Ulrich Germing, François Dreyfus, Sophie Park
Journal: Blood
Blood (2013) 122 (13): 2286–2288.
https://doi.org/10.1182/blood-2013-07-512442
Published: 2013
Journal Articles

Treatment of MDS with Excess Blasts by Bevacizumab Is Well Tolerated and Is Associated with a Decrease of VEGF Plasma Level.

Laurence Legros, Boranne Slama, Jean-Michel Karsenti, Norbert Vey, Shanti Natarajan-Ame, Eric Watel, Bruno Richard, Krimo Bouabdallah, Lionnel Mannone, Irit Touitou, Sebastien Huault, Jerome Durivault, Anne-Odile Hueber, Jean-Francois Michiels, Pierre Fenaux, Francois Dreyfus
Journal: Blood
Blood (2009) 114 (22): 2770.
https://doi.org/10.1182/blood.V114.22.2770.2770
Published: 2009
Journal Articles

Bortezomib + Low Dose Cytarabine in Int-2 and High Risk MDS. Interim Results of a Phase I/II Trial by the GFM.

Shanti Natarajan, Pierre Fenaux, Norbert Vey, A. Guerci, I. Coulibaly, A. Charbonnier, C. Ravoet, S. Courby, G. Etienne, M.P. Chaury, S. Cheze, A. Stamatoullas, L. Legros, E. Berger, A. Lescoute, S. Vaultier, F. Dreyfus
Journal: Blood
Blood (2007) 110 (11): 1453.
https://doi.org/10.1182/blood.V110.11.1453.1453
Published: 2007
Journal Articles

Prognostic Factors for Survival in Invasive Aspergillosis in Adult Oncohematological Patients.

Yasmine Nivoix, PharmD, Michel Velten, PhD, Valérie Letscher-Bru, PhD, Alireza Moghaddam, MD, Cécile Fohrer, MD, Bruno Lioure, MD, Karin Bilger, MD, Shanti Natarajan-Amé, MD, Philippe Lutun, MD, Luc Marcellin, MD, Jean-Pierre Bergerat, MD, Raoul Herbrecht, MD
Journal: Blood
Blood (2006) 108 (11): 2852.
https://doi.org/10.1182/blood.V108.11.2852.2852
Published: 2006